Center Book Partners LP Xeris Biopharma Holdings, Inc. Transaction History
Center Book Partners LP
- $1.7 Billion
- Q2 2025
A detailed history of Center Book Partners LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 1,594,229 shares of XERS stock, worth $11.6 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
1,594,229
Previous 472,075
237.71%
Holding current value
$11.6 Million
Previous $2.59 Million
187.34%
% of portfolio
0.44%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding XERS
# of Institutions
206Shares Held
89.5MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$75.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$71.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$28 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$27.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$26.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $992M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...